Summary
Methotrexate (MTX) has been coupled to various structurally related, polycationic synthetic branched polypeptides containing a poly[L-Lys] backbone. We describe here a novel, rapid and simple RP-HPLC approach and its application for a) the monitoring of MTX-macromolecule conjugate synthesis, b) analysis of the composition of conjugates samples, c) semi-preparative purification of target compounds from reagents and side products, and d) stability studies of MTX-branched polypeptide conjugate samples.
Similar content being viewed by others
References
Ghose, T.; Blair, A.H.; Kralovec, J.; Mammen, M.; Uadia, P.O. InAntibodymediated delivery systems: Rodwell, J.D., Ed. Marcel Dekker, New York,1988.
Furst, D.E.; Kremer, J.M.Arthritis Rheum. 1988,31, 305–314.
Vergne, P.; Liagre, B.; Bertinm, P.; Cook-Moreau, J.; Treves, R.; Beneytout, J.L.; Rigaud, M.J. Rheumatol. 1998,25, 433–440.
Mukhopadhyay, A.; Chaudhuri, G.; Arora, S.K.; Sehgal, S.; Basu, S.K.Science 1989,244, 705–707.
Endo, N.; Takeda, Y.; Umemoto, N.; Kishida, K.; Watanabe, K.; Saito, M.; Kato, Y.; Hara, T.Cancer Res. 1988,48, 3330–3335.
Kulkarni, P.N.; Blair, A.H.; Ghose, T.I.Cancer Res. 1981,41, 2700–2706.
Halbert, G.W.; Florence, A.T.J. Pharm. Pharmacol. 1989,41, 222–226.
Garnett, M.C.; Baldwin, R.W.Cancer Res. 1986,46, 2407–2412.
Endo, N.; Kato, Y.; Takeda, Y.; Saito, M.; Umemoto, N.; Kishida, K.; Hara, T.Cancer Res. 1987,47, 1076–1080.
Stehle, G.; Sinn, H.; Wunder, A.; Schrenk, H.H.; Schutt, S.; Maier Borst, W.; Heene, D.L.Anticancer Drugs 1997,8, 677–685.
Kosasih, A.; Bowman, B.J.; Wigent, R.J.; Ofner, C.M.Int. J. Pharm. 2000,204, 81–89.
Chakraborty, P.; Bhaduri, A.N.; Das, P.K.Biochem. Biophys. Res. Commun. 1990,166, 404–410.
Ryser, H.J.P.; Shen, W.C.Proc. Nat. Acad. Sci. USA 1978,75, 3867–3870.
McGuire, J.J.; Russell, C.A.Leukemia 1990,4, 48–52.
Hudecz, F.; Clegg, J.A.; Kajtár, J.; Embleton, M.J.; Pimm, M.V.; Szekerke, M.; Baldwin, R.W.Bioconjugate Chem. 1993,4, 25–33.
Sanzgiri, Y.; Blaton, C.D.; Gallo, J.M.Pharmaceutical Res. 1990,7, 418–421.
Manabe, Y.; Tsubota, T.; Haruta, Y.; Kataoka, K.; Okazaki, M.; Haisa, S.; Nakamura, K.; Kimura, I.J. Lab. Clin. Med. 1984,104, 445–454.
Przybylski, M.; Fell, E.; Ringsdorf, H.; Zaharko, D.S.Makromol. Chem 1978,179, 1719–1733.
Tsou, H.R.; Wallace, R.; Citarella, R.V.; Upeslacis, J. InPolymeric Drugs and Drug Delivery Systems: Dunn, R.L.; Ottenbrite R.O., Eds, ACS Symposium Series 469, ACS, Washington DC,1991.
Kralovec, J.; Singh, M.; Mammen, M.; Blair, A.H.; Ghose, T.Cancer Immunol. Immunother. 1989,29, 293–302.
Bures, L.; Lichy, A.; Bostik, J.; Spundova, M.Neoplasma 1990,37, 225–231.
McCrudden, E.A.; Tett, S.E.,J. Chromatogr. B Biomed. Sci. Appl. 1999,721, 87–92.
Elias, D.J.; Hirschowitz, L.; Kline, L.E.; Koener, J.F.; Dillman, R.O.; Walker, L.E.; Robb, J.A.; Timms, R.M.Cancer Research 1990,50, 4154–4159.
Hudecz, F.; Garnett, M.C.; Khan, T.; Baldwin, R.W.Biomed. Chromatography 1992,6, 128–132.
Mező G.; Kajtár, J.; Hudecz, F.; Szekerke, M.Biopolymers 1993,33, 873–883.
Hudecz, F.; Pimm, M.V.; Rajnavölgyi, É.; Mező, G.; Fabra, A.; Gaál, D.; Kovács, A.L.; Horváth, A.; Szekerke, M.Bioconjugate Chem. 1999,10, 781–790.
Mező, G.; Kajtár, J.; Nagy, I.; Szekerke, M.; Hudecz, F.Biopolymers 1997,42, 719–730.
Hudecz, F.; Kovács, P.; Kutassi-Kovács, S.; Kajtár, J.Colloid and Polymer Sci. 1984,262, 208–212.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kóczán, G., Hudecz, F. Novel approach for the purification and analysis of methotrexate-branched polymeric polypeptide conjugates by HPLC. Chromatographia 55, 163–169 (2002). https://doi.org/10.1007/BF02492137
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02492137